0001209191-17-059752.txt : 20171108 0001209191-17-059752.hdr.sgml : 20171108 20171108162331 ACCESSION NUMBER: 0001209191-17-059752 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171106 FILED AS OF DATE: 20171108 DATE AS OF CHANGE: 20171108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Townsend Christopher G CENTRAL INDEX KEY: 0001555359 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15787 FILM NUMBER: 171186903 MAIL ADDRESS: STREET 1: METLIFE STREET 2: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: METLIFE INC CENTRAL INDEX KEY: 0001099219 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 134075851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 BUSINESS PHONE: 212-578-5500 MAIL ADDRESS: STREET 1: 200 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10166 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-06 1 0001099219 METLIFE INC MET 0001555359 Townsend Christopher G LEVEL 20, CITYPLAZA 3 14 TAIKOO WAN ROAD TAIKOO SHING K3 00000 HONG KONG 0 1 0 0 President, Asia Common Stock 2017-11-06 4 M 0 25181 45.15 A 25181 D Common Stock 2017-11-06 4 S 0 25181 54.343 D 0 D Common Stock 2017-11-06 4 M 0 17425 45.91 A 17425 D Common Stock 2017-11-06 4 S 0 17425 54.289 D 0 D Common Stock 2017-11-06 4 M 0 13106 34.33 A 13106 D Common Stock 2017-11-06 4 S 0 13106 54.20 D 0 D Employee Stock Option (Right to Buy) 45.15 2017-11-06 4 M 0 25181 0.00 D 2024-02-24 Common Stock 25181 0 D Employee Stock Option (Right to Buy) 45.91 2017-11-06 4 M 0 17425 0.00 D 2025-02-23 Common Stock 17425 8713 D Employee Stock Option (Right to Buy) 34.33 2017-11-06 4 M 0 13106 0.00 D 2026-02-22 Common Stock 13106 26216 D The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(3) and (4) to this Form 4. The shares were sold in multiple transactions at prices $54.131 to $54.490, inclusive. The shares were sold in multiple transactions at prices $54.225 to $54.370, inclusive. The shares were sold in multiple transactions at prices $54.061 to $54.325, inclusive. The options became exercisable in three equal installments on February 25, 2015, 2016 and 2017. The options became exercisable in three equal installments on February 24, 2016, 2017 and 2018. The options became exercisable in three equal installments on February 23, 2017, 2018 and 2019. Mark A. Schuman, authorized signer 2017-11-08